Ben R. Taylor - Chief Financial Officer at RECURSION PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
RXRX on Nasdaq
All Insider Reports
All Insider Reports

Ben R. Taylor - trading volume in the past year for RECURSION PHARMACEUTICALS, INC.

Holdings reported by Ben R. Taylor for RECURSION PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 1,220,683 $4,858,318 $3.98 06 Feb 2026 Direct
Stock Option (Right to Buy) 289,837 16 Jun 2025 Direct Class A Common Stock 0

Transactions reported by Ben R. Taylor for RECURSION PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.